EUVIMEDEUVIMED entdecken
Leitlinie

EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism

Giovanni Corona, Luís Afonso Morgado, Luca Boeri, Paolo Capogrosso, Andrea Cocci, Marij Dinkelman-Smit, Anthony Emmanuel, Marco Falcone, Christian Fuglesang S Jensen, Murat Gül, Arif Kalkanli, Ates Kadioğlu und 5 weitere

European Urology Focus · 2026-10 · 12 (5) · 965-970

DOI: 10.1016/j.euf.2026.04.015 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Urology Focus, 2026-10. Verfasst von Giovanni Corona und 16 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Medical Department, Maggiore-Bellaria Hospital, Bologna, Italy. Hauptthemen laut MEDLINE: Hypogonadism, Testosterone, Sex Hormone-Binding Globulin, Reproductive Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Boston Scientific Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Despite the consensus that diagnosis of male hypogonadism requires both biochemical and clinical criteria, important uncertainties remain regarding preanalytical conditions, assay selection, and the role of free testosterone (T) and sex hormone-binding globulin (SHBG) measurements. To address these issues, this study provides a summary of the European Association of Urology Guidelines on Sexual and Reproductive Health (SRH) recommendations for the measurement of total T and biochemical diagnosis of male hypogonadism. METHODS: For the 2026 guidelines on SRH, new and relevant evidence was identified, collated, and appraised via a structured assessment of the literature. Database searches included MEDLINE, EMBASE, and the Cochrane Library. Recommendations within the guidelines were developed by the panel to prioritize clinically important care decisions. The strength of each recommendation was determined according to a balance between the desirable and undesirable consequences of alternative management strategies, the quality of the evidence (including the certainty of estimates), and the nature and variability of patient values and preferences. KEY FINDINGS AND LIMITATIONS: Key recommendations emphasize the importance of measuring total T in a fasting state and in the morning (7:00-10:00 AM). Immunoassays remain clinically acceptable for total T measurement when liquid chromatography-tandem mass spectrometry is unavailable. A T level of ≤12 nmol/l continues to be the recommended threshold for diagnosing symptomatic male hypogonadism in clinical practice. Emerging evidence supports broader use of SHBG to prevent misdiagnosis of male hypogonadism. Calculated free T, derived from total T, SHBG, and albumin levels, should be considered in conditions known to affect circulating SHBG levels. CONCLUSIONS AND CLINICAL IMPLICATIONS: Accurate biochemical confirmation of male hypogonadism requires standardized sampling procedures and validated assays. Total T remains the cornerstone of diagnosis; however, SHBG and calculated free T are essential in men with altered binding protein levels. Recent data, although based on limited evidence, support the use of calculated free T even in healthy individuals and not just in patients with conditions associated with potential alterations in SHBG levels. PATIENT SUMMARY: This paper explains how testosterone (T) should be measured to diagnose low T (male hypogonadism). Testing should be done in the morning and after fasting. In some cases, additional measurements such as SHBG and calculated free T may help improve diagnostic accuracy, although current evidence supporting their use is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypogonadismTestosteroneSex Hormone-Binding GlobulinReproductive HealthHumansMaleEurope

Stichwörter der Autor:innen

DiagnosisFree testosteroneHypogonadismMeasurementSex hormone-binding globulinTestosterone

Substanzen

TestosteroneSex Hormone-Binding Globulin

Autor:innen und Institutionen

  • Endocrinology Unit, Medical Department, Maggiore-Bellaria Hospital, Bologna, Italy.
  • Urology Service, Centro Hospitalar Universitário São João, Porto, Portugal; Department of Biomedicine, Faculty of Medicine, Porto University, Porto, Portugal.
  • Department of Urology, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Medicine and Technological Innovations (DIMIT)/Unit of Urology, Circolo & Fondazione Macchi Hospital, University of Insubria, Varese, Italy.
  • Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy.
  • Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Förderung

  • Boston Scientific Japan

Zitieren

APA

Corona, G., Morgado, L. A., Boeri, L., Capogrosso, P., Cocci, A., Dinkelman-Smit, M., Emmanuel, A., Falcone, M., Jensen, C. F. S., Gül, M., Kalkanli, A., Kadioğlu, A., Russo, G. I., Serefoglu, E. C., Verze, P., Minhas, S., & Salonia, A. (2026). EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism. European Urology Focus, 12(5), 965-970. https://doi.org/10.1016/j.euf.2026.04.015

Vancouver

Corona G, Morgado LA, Boeri L, Capogrosso P, Cocci A, Dinkelman-Smit M, et al. EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism. European Urology Focus. 2026;12(5):965-970. doi:10.1016/j.euf.2026.04.015

BibTeX
@article{Corona2026,
  author = {Corona, Giovanni and Morgado, Luís Afonso and Boeri, Luca and Capogrosso, Paolo and Cocci, Andrea and Dinkelman-Smit, Marij and Emmanuel, Anthony and Falcone, Marco and Jensen, Christian Fuglesang S and Gül, Murat and Kalkanli, Arif and Kadioğlu, Ates and Russo, Giorgio I and Serefoglu, Ege Can and Verze, Paolo and Minhas, Suks and Salonia, Andrea},
  title = {EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism},
  journal = {European Urology Focus},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {965--970},
  doi = {10.1016/j.euf.2026.04.015}
}
Kostenlos starten →